Healthequity (HQY) Capital Expenditures (2013 - 2026)

Healthequity's Capital Expenditures history runs 14 years deep, the most recent figure standing at $15.9 million for Q2 2026.

• On a quarterly basis, Capital Expenditures fell 0.79% year-over-year to $15.9 million in Q2 2026; TTM through Apr 2026 was -$111000.0, a 100.64% decrease from a year earlier, with the FY2026 full-year figure at $16000.0, down 99.23% from the prior year.
• Capital Expenditures rose to $15.9 million in Q2 2026 per HQY's latest filing, from -$36.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $35.9 million in Q4 2025 and bottomed at -$36.8 million in Q1 2026.
• The 5-year median for Capital Expenditures is $6.3 million (2024), against an average of $3.1 million.
• Across the five-year window, Capital Expenditures surged 2127.05% in 2025 and plunged 1958.04% in 2026, its largest moves.
• Year by year, Capital Expenditures stood at $32.9 million in 2022, then slumped by 64.71% to $11.6 million in 2023, then sank by 317.08% to -$25.2 million in 2024, then jumped by 242.37% to $35.9 million in 2025, then tumbled by 55.64% to $15.9 million in 2026.
• Per Business Quant, the three latest HQY Capital Expenditures figures stand at $15.9 million (Q2 2026), -$36.8 million (Q1 2026), and $35.9 million (Q4 2025).